glp-1 and type 2 diabetes Novel GLP-1–Based Medications for Obesity GLP-1 Receptor Agonists for Type

This is an FDA-approved branded product, not compounded semaglutide

Target Indication Insights Why did the type 2 diabetes segment dominate the obesity GLP-1 market

Oxidative RNA damage can impair protein translation, and damaged RNA can degrade prematurely, further impairs the synthesis of essential proteins (65)

Age-Related Macular Degeneration Wet Forms Including Macular Neovascularization

Additionally, factors secreted by retinal cells, like IL-6, promote the proliferation of different retinal cell types, contributing to the formation of new blood vessels and the progression of diabetic retinopathy (84)

5 The research group intends to extend its data collection across additional imaging centres to provide a stronger evidence base for future national guidance